Technical Analysis for CTSO - Cytosorbents Corporation

Grade Last Price % Change Price Change
grade C 9.9 3.34% 0.32
CTSO closed up 3.34 percent on Friday, November 16, 2018, on 73 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical CTSO trend table...

Date Alert Name Type % Chg
Nov 16 Crossed Above 20 DMA Bullish 0.00%
Nov 16 NR7 Range Contraction 0.00%
Nov 14 Down 3 Days in a Row Weakness 9.27%
Nov 14 Down 4 Days in a Row Weakness 9.27%
Nov 14 Down 5 Days in a Row Weakness 9.27%
Nov 13 Calm After Storm Range Contraction 3.77%
Nov 13 Down 3 Days in a Row Weakness 3.77%
Nov 13 Down 4 Days in a Row Weakness 3.77%
Nov 12 Calm After Storm Range Contraction 2.27%
Nov 12 Down 3 Days in a Row Weakness 2.27%

Older signals for CTSO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
CytoSorbents Corporation, a development stage company, is engaged in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent polymer technology. The company develops its adsorbent polymer technology for various applications in the medical field, primarily to provide blood purification for acute and chronic health complications associated with blood toxicity. Its principal product is CytoSorb device, an extracorporeal cytokine filter designed for the adjunctive therapy in the treatment of sepsis; for the adjunctive therapy in other critical care applications, including acute respiratory distress syndrome, severe burn injury, trauma, and pancreatitis; to prevent and treat organ dysfunction in brain-dead organ donors to increase the number and quality of viable organs harvested from donors; and for the prevention and treatment of post-operative complications of cardiopulmonary bypass surgery. The company is also developing HemoDefend blood purification technology platform to reduce contaminants in the blood supply that can cause transfusion reactions or disease when administering blood and blood products to patients; and ContrastSorb for the removal of IV contrast in blood administered during CT imaging, an angiogram, or during a vascular interventional radiology procedure to reduce the risk of contrast-induced nephropathy. In addition, it is developing BetaSorb device for the prevention and treatment of health complications caused by the accumulation of metabolic toxins in patients with chronic renal failure; and DrugSorb, an extracorporeal hemoperfusion cartridge designed to remove toxic chemicals from the blood. The company was formerly known as MedaSorb Technologies Corporation and changed its name to CytoSorbents Corporation in May 2010. CytoSorbents Corporation was founded in 1997 and is based in Monmouth Junction, New Jersey.
Is CTSO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 14.95
52 Week Low 5.8
Average Volume 214,573
200-Day Moving Average 10.2665
50-Day Moving Average 11.3585
20-Day Moving Average 9.8915
10-Day Moving Average 9.894
Average True Range 0.7543
ADX 29.5
+DI 19.1138
-DI 21.9662
Chandelier Exit (Long, 3 ATRs ) 9.7371
Chandelier Exit (Short, 3 ATRs ) 10.9629
Upper Bollinger Band 10.8717
Lower Bollinger Band 8.9113
Percent B (%b) 0.5
BandWidth 19.819037
MACD Line -0.4231
MACD Signal Line -0.4789
MACD Histogram 0.0559
Fundamentals Value
Market Cap 278.51 Million
Num Shares 28.1 Million
EPS -0.37
Price-to-Earnings (P/E) Ratio -26.76
Price-to-Sales 13.98
Price-to-Book 21.53
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 10.64
Resistance 3 (R3) 10.58 10.28 10.51
Resistance 2 (R2) 10.28 10.09 10.31 10.47
Resistance 1 (R1) 10.09 9.98 10.19 10.15 10.43
Pivot Point 9.79 9.79 9.84 9.82 9.79
Support 1 (S1) 9.60 9.60 9.70 9.66 9.37
Support 2 (S2) 9.30 9.49 9.33 9.33
Support 3 (S3) 9.11 9.30 9.29
Support 4 (S4) 9.17